Sbir topic 454: a software tool for standardization of radiotherapy treatment plans for AI validation
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91023C00026
- Awardee
-
Oncospace Inc. UEI HSG5CY5VWW33
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $399,870
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20231 · Posted Jul 20, 2022
- Contract value 100% obligated
- $399,870.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21205, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This SBIR Phase I contract award of $399,870 to Oncospace Inc. will fund research and development of a software tool for standardizing radiotherapy treatment plans to support artificial intelligence validation. The contract responds to National Institutes of Health National Cancer Institute SBIR Topic 454 and will take place over one year in Baltimore, Maryland. It was awarded under the NIH/CDC SBIR solicitation seeking innovative solutions across over 125 topics related to cancer treatment, infectious diseases, aging, and public health. As a total small business set-aside, this award furthers the solicitation's goal of supporting small businesses through the NIH and CDC's missions in biomedical and public health research.
Quick answers
Who was awarded contract 75N91023C00026?
75N91023C00026 was awarded to Oncospace Inc. by National Cancer Institute (National Institutes of Health) on August 10, 2023.
How much is contract 75N91023C00026 worth?
The government has obligated $399,870 on 75N91023C00026.
Was contract 75N91023C00026 competed?
The extent of competition for 75N91023C00026 was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award